Overall, 2018 showed favorable trends for opioid use with declines in both utilization and cost. Understanding the top opioid medications being filled and impacting spend can help guide decision-making and aid in identifying opportunities for intervention particularly through formulary controls, utilization management strategies, and through insight into regulatory changes and juris-specific rule application. Watch the video blog to learn more.
More stories
Workers' Comp
Case Study
Unbundled Early Intervention Program Leads to Greater Transparency
Workers' Comp
Article
Empowering Excellence: How Our Dedicated Team Elevates Care for Injured Employees
Our employees’ unwavering dedication to continuous improvement and quality assurance lies at the heart of our customer-centric approach, utilizing
Workers' Comp
Article
Ask The Pharmacist: GLP-1 Drugs in Workers’ Compensation
Will GLP-1 weight loss drugs become more prevalent in workers’ compensation? Glucagon-like peptide 1 (GLP-1)
Workers' Comp
Article
The Regulatory Rollercoaster: A High-Stakes Game of Collaboration and Adaptability
As the workers' compensation and auto industry braces itself for the regulatory changes sweeping across Michigan, Florid
Workers' Comp
Article
6 Considerations for Medical Transportation Arrangements for Injured Employees
Beyond convenience, reliable transportation prevents missed appointments that can delay recovery and worsen health outcomes.
Mitchell
Article
Current Used Vehicle Market Conditions: Q2 2024
May/June 2024 Kontos Kommentary The following commentary is produced by Tom Kontos, Chief Economist, ADESA Auctions.